We are live on ! Find out more
BOS

Bingham Osborn & Scarborough Portfolio holdings

AUM $1.42B
1-Year Est. Return 27.88%
This Fund
S&P 500
This Quarter Est. Return
+3.22%
1 Year Est. Return
+27.88%
3 Year Est. Return
+51.71%
5 Year Est. Return
+102.3%
10 Year Est. Return
AUM
$1.12B
AUM Growth
+$42.4M
Cap. Flow
+$8.66M
Cap. Flow %
0.77%
Top 10 Hldgs %
81.23%
Holding
153
New
10
Increased
73
Reduced
47
Closed
7

Sector Composition

Rank Sector Weight
1 Technology 5.27%
2 Financials 2.24%
3 Consumer Discretionary 1.6%
4 Industrials 1.43%
5 Consumer Staples 1.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHW
26
Charles Schwab
SCHW
$185B
$4.03M 0.36%
100,183
-2,299
-2% -$100K
IWD icon
27
iShares Russell 1000 Value ETF
IWD
$83.4B
$3.98M 0.35%
31,279
+434
+1% +$54.3K
BAC icon
28
Bank of America
BAC
$440B
$3.51M 0.31%
121,012
+779
+0.6% +$22.5K
DXCM icon
29
DexCom
DXCM
$32.8B
$3.14M 0.28%
83,824
+8,964
+12% +$282K
CRM icon
30
Salesforce
CRM
$156B
$2.58M 0.23%
16,972
-2,988
-15% -$468K
XLK icon
31
State Street Technology Select Sector SPDR ETF
XLK
$123B
$2.5M 0.22%
64,086
+1,092
+2% +$41.6K
CVX icon
32
Chevron
CVX
$379B
$2.31M 0.21%
18,558
+802
+5% +$97K
JAZZ icon
33
Jazz Pharmaceuticals
JAZZ
$16.4B
$2.2M 0.2%
15,412
JPM icon
34
JPMorgan Chase
JPM
$950B
$2.02M 0.18%
18,088
-550
-3% -$60.6K
ABBV icon
35
AbbVie
ABBV
$431B
$1.65M 0.15%
22,728
-1,193
-5% -$93.8K
IEMG icon
36
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$1.63M 0.15%
31,733
+4,167
+15% +$213K
XOM icon
37
ExxonMobil
XOM
$638B
$1.6M 0.14%
20,880
+444
+2% +$34.4K
BRK.A icon
38
Berkshire Hathaway Class A
BRK.A
$1.11T
$1.59M 0.14%
5
IVE icon
39
iShares S&P 500 Value ETF
IVE
$49.8B
$1.57M 0.14%
13,496
+3,162
+31% +$362K
BA icon
40
Boeing
BA
$187B
$1.51M 0.13%
4,140
+622
+18% +$227K
IDV icon
41
iShares International Select Dividend ETF
IDV
$8.48B
$1.45M 0.13%
47,070
+445
+1% +$13.8K
WTW icon
42
Willis Towers Watson
WTW
$31.5B
$1.39M 0.12%
7,249
+4
+0.1% +$724
EFV icon
43
iShares MSCI EAFE Value ETF
EFV
$29.2B
$1.37M 0.12%
28,491
+2,647
+10% +$129K
JNJ icon
44
Johnson & Johnson
JNJ
$614B
$1.36M 0.12%
9,768
-565
-5% -$78.2K
GOOGL icon
45
Alphabet (Google) Class A
GOOGL
$4.62T
$1.35M 0.12%
24,880
-20
-0.1% -$1.16K
IWN icon
46
iShares Russell 2000 Value ETF
IWN
$14.7B
$1.3M 0.12%
10,789
+2,098
+24% +$253K
SBUX icon
47
Starbucks
SBUX
$120B
$1.28M 0.11%
15,231
+88
+0.6% +$6.9K
ABT icon
48
Abbott
ABT
$182B
$1.21M 0.11%
14,392
-633
-4% -$49.8K
DIA icon
49
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.5B
$1.2M 0.11%
4,500
+119
+3% +$31.1K
GOOG icon
50
Alphabet (Google) Class C
GOOG
$4.59T
$1.19M 0.11%
21,960
-2,260
-9% -$130K

Similar funds

Bingham Osborn & Scarborough's Q2 2019 Portfolio in Review

As of Q2 2019, Bingham Osborn & Scarborough held 153 positions worth $1.12B, up 3.9% from $1.08B the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Bingham Osborn & Scarborough's Q2 2019 filing shows 10 new, 73 increased, 47 reduced and 7 closed positions. Its largest new stake was Vanguard Morningstar Small-Cap ETF: 2,569 shares worth $403K. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.18M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 5.3% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Bingham Osborn & Scarborough's largest Q2 2019 buy was Vanguard Morningstar Small-Cap ETF: 2,569 shares worth $403K.
  • Bingham Osborn & Scarborough added most to iShares Core S&P 500 ETF in Q2 2019, an estimated $9.43M increase.
  • Bingham Osborn & Scarborough's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.18M.
  • Bingham Osborn & Scarborough fully exited Agios Pharmaceuticals in Q2 2019, selling an estimated $738K.
  • Bingham Osborn & Scarborough's ten largest holdings make up 81% of its $1.12B portfolio in Q2 2019.
  • Bingham Osborn & Scarborough opened 10 new positions and closed 7 in Q2 2019.
  • Bingham Osborn & Scarborough's portfolio value rose 3.9% quarter-over-quarter to $1.12B.

Based on Bingham Osborn & Scarborough's 13F filing for Q2 2019, filed 2 Aug 2019.